1. Home
  2. UA vs APLS Comparison

UA vs APLS Comparison

Compare UA & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UA
  • APLS
  • Stock Information
  • Founded
  • UA 1996
  • APLS 2009
  • Country
  • UA United States
  • APLS United States
  • Employees
  • UA N/A
  • APLS N/A
  • Industry
  • UA Apparel
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • UA Consumer Discretionary
  • APLS Health Care
  • Exchange
  • UA Nasdaq
  • APLS Nasdaq
  • Market Cap
  • UA 2.6B
  • APLS 2.2B
  • IPO Year
  • UA N/A
  • APLS 2017
  • Fundamental
  • Price
  • UA $6.56
  • APLS $19.91
  • Analyst Decision
  • UA
  • APLS Buy
  • Analyst Count
  • UA 0
  • APLS 19
  • Target Price
  • UA N/A
  • APLS $37.39
  • AVG Volume (30 Days)
  • UA 2.7M
  • APLS 1.9M
  • Earning Date
  • UA 08-07-2025
  • APLS 07-31-2025
  • Dividend Yield
  • UA N/A
  • APLS N/A
  • EPS Growth
  • UA N/A
  • APLS N/A
  • EPS
  • UA N/A
  • APLS N/A
  • Revenue
  • UA $5,164,310,000.00
  • APLS $775,839,000.00
  • Revenue This Year
  • UA N/A
  • APLS $1.01
  • Revenue Next Year
  • UA $2.72
  • APLS $22.14
  • P/E Ratio
  • UA N/A
  • APLS N/A
  • Revenue Growth
  • UA N/A
  • APLS 48.04
  • 52 Week Low
  • UA $4.62
  • APLS $16.10
  • 52 Week High
  • UA $10.62
  • APLS $42.47
  • Technical
  • Relative Strength Index (RSI)
  • UA 52.83
  • APLS 62.09
  • Support Level
  • UA $6.54
  • APLS $17.35
  • Resistance Level
  • UA $6.88
  • APLS $19.63
  • Average True Range (ATR)
  • UA 0.24
  • APLS 0.81
  • MACD
  • UA -0.02
  • APLS 0.23
  • Stochastic Oscillator
  • UA 35.62
  • APLS 80.24

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: